## Abstract The Wnt/Ξ²βcatenin signaling pathway is inactivated by Wnt antagonists in most cancers and IGFBPβ4 is an antagonist of the Wnt/ Ξ²βcatenin signaling pathway. However, the function of IGFBPβ4 is not currently understood in renal cell carcinoma (RCC). We initially found that the expression
Aberrant activity of Wnt/Frizzled signaling pathway in renal cancer cell lines
β Scribed by Tong Zang; Liyan Zhuang; Zhiwen Zhang; Dianqi Xin; Yinglu Guo
- Publisher
- Springer
- Year
- 2000
- Tongue
- English
- Weight
- 391 KB
- Volume
- 45
- Category
- Article
- ISSN
- 1001-6538
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
We screened 1434 small heterocyclic molecules and identified thirteen 2,3,6-trisubstituted quinoxaline derivatives that were able to inhibit the Wnt/b-catenin signal pathway and cell proliferation. In the screen, some of the hit compounds such as the ethylene group-coupled quinoxaline derivatives we
Breast cancers frequently over-express a number of growth factor receptors. In addition, elevated src family kinase activity is present in a percentage of these neoplasms and has been implicated in signal transduction in these cells. Therefore, inhibiting tyrosine kinase activity is a potential appr